FibroGen
FGEN
$0.35
Share price
4.24%
Change (1 day)
-82.67%
Change (1 year)
Categories
Revenue for FibroGen (FGEN)
Revenue in 2024 (TTM): S$35.91 Million
According to FibroGen's latest financial reports the company's current revenue (TTM 
) is S$39.64 Million. a decrease over the revenue in the year 2023 that were of S$0.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for FibroGen from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$40.26 M | -79.37% |
| 2023 | S$0.19 B | 3.43% |
| 2022 | S$0.18 B | -40.69% |
| 2021 | S$0.31 B | 36.38% |
| 2020 | S$0.23 B | -32.57% |
| 2019 | S$0.34 B | 18.9% |
| 2018 | S$0.29 B | 52.36% |
| 2017 | S$0.19 B | -26.53% |
| 2016 | S$0.25 B | 1.61% |
| 2015 | S$0.25 B | 40.68% |
| 2014 | S$0.18 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | S$5.85 B | 14,660.30% | 🇺🇸 USA |
 | S$0.15 B | 280.70% | 🇺🇸 USA |
 | S$15.65 M | -60.51% | 🇺🇸 USA |